Resonait Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Resonait General Information

Description

Developer of a mental well-being platform designed for understanding mental health through EEG. The company's platform aims at accelerating the pathway to recovery from depression with home-use medical devices, enabling users to get rid of their mental illness and live a happy life.

Contact Information

Website
www.resonait.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Terrigal, New South Wales 2260
  • Australia
Primary Industry
Therapeutic Devices
Other Industries
Clinics/Outpatient Services
Vertical(s)
LOHAS & Wellness, Wearables & Quantified Self, Artificial Intelligence & Machine Learning
Corporate Office
  • Terrigal, New South Wales 2260
  • Australia

Resonait Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resonait Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC Completed Generating Revenue
3. Grant 01-Nov-2023 Completed Generating Revenue
2. Accelerator/Incubator 20-Feb-2023 $20K Completed Generating Revenue
1. Accelerator/Incubator 22-Nov-2022 $20K $20K Completed Startup
To view Resonait’s complete valuation and funding history, request access »

Resonait Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Resonait Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024407619-A1 Clinical brain network identification device Active 21-Dec-2023
AU-2024407619-B2 Clinical brain network identification device Active 21-Dec-2023
AU-2026205545-A1 Clinical brain network identification device Pending 21-Dec-2023
EP-4829986-A1 Clinical brain network identification device Pending 21-Dec-2023
WO-2025129277-A1 Clinical brain network identification device Inactive 21-Dec-2023 G16H50/20
To view Resonait’s complete patent history, request access »

Resonait Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
NSW Government (Energy) Government
Startmate Accelerator/Incubator Minority
The George Institute for Global Health VC-Backed Company Minority
UNSW Founders Accelerator/Incubator
Hatcher+ Venture Capital Minority
To view Resonait’s complete investors history, request access »

Ready to get started?

Request a free trial

Resonait FAQs

  • When was Resonait founded?

    Resonait was founded in 2022.

  • Where is Resonait headquartered?

    Resonait is headquartered in Terrigal, Australia.

  • What industry is Resonait in?

    Resonait’s primary industry is Therapeutic Devices.

  • Is Resonait a private or public company?

    Resonait is a Private company.

  • What is Resonait’s current revenue?

    The current revenue for Resonait is .

  • How much funding has Resonait raised over time?

    Resonait has raised $20K.

  • Who are Resonait’s investors?

    NSW Government (Energy), Startmate, The George Institute for Global Health, UNSW Founders, and Hatcher+ have invested in Resonait.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process